Remibrutinib in inadequately controlled cholinergic urticaria
A real-world case series.
Wang D, Yi M, Zhu Y, Zhang W, Chen S, Xie L, Tang H, Shen Y
Journal of the American Academy of DermatologyIn the feed 4 Sep 2026, published online 4 Sep 2026, issue 2026 Sep 04, added to PubMed 4 Sep 2026
Topics: UrticariaJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42697489 · DOI 10.1016/j.jaad.2026.09.002